Plasma exchange in a patient with heterozygous familial hypercholesterolaemia resistant to drug therapy.
A 40-year-old male with heterozygous familial hypercholesterolaemia was resistant to combined drug treatment with cholestyramine and nicotinic acid in adequate doses. He had angina pectoris and evidence of three vessel disease in the coronary angiogram. Repeated plasma exchange at intervals of 1-3 weeks simultaneously with combined drug treatment decreased the plasma cholesterol levels by nearly 40%. There were also signs of regression of xanthomata and some improvement of his angina pectoris. No progression of atherosclerosis was seen angiographically after two years treatment. Plasma exchange may be a therapeutic alternative in drug-resistant familial hypercholesterolaemia.
D000328:Adult; D002792:Cholestyramine Resin / Q000627:therapeutic use; D004351:Drug Resistance; D006579:Heterozygote; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000235:genetics / Q000628:therapy*; D008297:Male; D009539:Nicotinic Acids / Q000627:therapeutic use; D010951:Plasma Exchange
D009539:Nicotinic Acids; D002792:Cholestyramine Resin